BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9546366)

  • 1. Analysis and clinical implications of p53 gene mutations and human papillomavirus type 16 and 18 infection in primary adenocarcinoma of the uterine cervix.
    Tenti P; Pavanello S; Padovan L; Spinillo A; Vesentini N; Zappatore R; Migliora P; Zara C; Ranzani GN; Carnevali L
    Am J Pathol; 1998 Apr; 152(4):1057-63. PubMed ID: 9546366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
    Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
    Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
    Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
    Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenocarcinoma of the uterine cervix in Ireland and Sweden: human papillomavirus infection and biologic alterations.
    Skyldberg BM; Murray E; Lambkin H; Kelehan P; Auer GU
    Mod Pathol; 1999 Jul; 12(7):675-82. PubMed ID: 10430271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix.
    Ferguson AW; Svoboda-Newman SM; Frank TS
    Mod Pathol; 1998 Jan; 11(1):11-8. PubMed ID: 9556417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India.
    Munirajan AK; Kannan K; Bhuvarahamurthy V; Ishida I; Fujinaga K; Tsuchida N; Shanmugam G
    Gynecol Oncol; 1998 Jun; 69(3):205-9. PubMed ID: 9648588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
    Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
    Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
    Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
    Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.
    Zielinski GD; Snijders PJ; Rozendaal L; Daalmeijer NF; Risse EK; Voorhorst FJ; Jiwa NM; van der Linden HC; de Schipper FA; Runsink AP; Meijer CJ
    J Pathol; 2003 Dec; 201(4):535-43. PubMed ID: 14648656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration status of virus DNA and p53 codon 72 polymorphism in human papillomavirus type 16 positive cervical cancers.
    Szarka K; Veress G; Juhász A; Kónya J; Sápy T; Soós G; Hernádi Z; Gergely L
    Anticancer Res; 2000; 20(3B):2161-7. PubMed ID: 10928171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elderly Japanese women with cervical carcinoma show higher proportions of both intermediate-risk human papillomavirus types and p53 mutations.
    Nakagawa S; Yoshikawa H; Jimbo H; Onda T; Yasugi T; Matsumoto K; Kino N; Kawana K; Kozuka T; Nakagawa K; Aoki M; Taketani Y
    Br J Cancer; 1999 Mar; 79(7-8):1139-44. PubMed ID: 10098748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix.
    Waggoner SE; Anderson SM; Van Eyck S; Fuller J; Luce MC; Herbst AL
    Obstet Gynecol; 1994 Sep; 84(3):404-8. PubMed ID: 8058239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Human papillomavirus, human cytomegalovirus and p53 gene in cervical carcinoma].
    Zhao W; Si J; Li K
    Zhonghua Fu Chan Ke Za Zhi; 1995 Nov; 30(11):654-7. PubMed ID: 8745488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity.
    Chiba I; Shindoh M; Yasuda M; Yamazaki Y; Amemiya A; Sato Y; Fujinaga K; Notani K; Fukuda H
    Oncogene; 1996 Apr; 12(8):1663-8. PubMed ID: 8622886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus DNA in invasive cervical carcinomas and its association with patient survival: a nested case-control study.
    Franco E; Bergeron J; Villa L; Arella M; Richardson L; Arseneau J; Stanimir G
    Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):271-5. PubMed ID: 8722218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between c-Ki-ras mutations, HPV types, and prognostic indicators in invasive endocervical adenocarcinomas.
    Koulos JP; Wright TC; Mitchell MF; Silva E; Atkinson EN; Richart RM
    Gynecol Oncol; 1993 Mar; 48(3):364-9. PubMed ID: 8385060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correspondence re: Ferguson AM, Svoboda-Newman SM, Frank TS: Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix. Mod Pathol 1:11-18, 1998.
    Tenti P; Zappatore R; Carnevali L
    Mod Pathol; 1999 Dec; 12(12):1192-3. PubMed ID: 10619275
    [No Abstract]   [Full Text] [Related]  

  • 18. Loss of heterozygosity of the retinoblastoma and p53 genes in primary cervical carcinomas with human papillomavirus infection.
    Kim JW; Lee CG; Han SM; Kim KS; Kim JO; Lee JM; Kim IK; Namkoong SE
    Gynecol Oncol; 1997 Nov; 67(2):215-21. PubMed ID: 9367711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between HPV positivity and state of the p53 gene in cervical carcinoma cell lines.
    Iwasaka T; Oh-uchida M; Matsuo N; Yokoyama M; Fukuda K; Hara K; Fukuyama K; Hori K; Sugimori H
    Gynecol Oncol; 1993 Jan; 48(1):104-9. PubMed ID: 8380785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.